Single dose of rituximab for new-onset myasthenia gravis associated with reduced risk of disease manifestations – The RINOMAX Randomized Clinical Trial
1. In this randomized clinical trial, among 47 individuals, the proportion with minimal myasthenia gravis (MG) manifestations with only low ...